Vienna Insurance Group Stock
Price
Target price
€66.50
€66.50
1.520%
1.0
1.520%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Vienna Insurance Group Stock
There is an upward development for Vienna Insurance Group compared to yesterday, with an increase of €1.00 (1.520%).
Pros and Cons of Vienna Insurance Group in the next few years
Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Vienna Insurance Group vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Vienna Insurance Group | 1.520% | 5.892% | 1.838% | 89.189% | -0.449% | 160.784% | 202.273% |
| Uniqa Versicherungen | 2.590% | 6.386% | 7.902% | 94.626% | 8.042% | 110.088% | 158.295% |
| ASR Nederland NV | 1.200% | 3.789% | 3.513% | 27.652% | 2.866% | 44.818% | 83.113% |
| Ageas S.A. NV | 1.520% | 3.664% | 6.885% | 24.074% | 6.172% | 47.304% | 38.189% |
News
This Vanguard ETF Has Doubled the S&P 500's Returns Year to Date. Should You Buy It?
Over the past few years, you could simply invest in the S&P 500 and enjoy strong double-digit annual returns. Tilt more heavily toward megacap growth, and you likely did better. There wasn't a big
Is the Vanguard Dividend Appreciation ETF a Buy Now?
The Vanguard Dividend Appreciation ETF (NYSEMKT: VIG) has had a tough start to 2026. Sure, it's beating the S&P 500 by about 3 percentage points year to date (as of Feb. 9), but it's ranking well in
These 2 Dividend ETFs Could Shine if Rate Cuts Hit Again in 2026
With the Federal Reserve having enacted a rate-cutting cycle in each of the past two years—and the market pricing in the likelihood of additional cuts later in 2026, according to CME Group’s
